Nanobiotix S.A. (NBTX) Financials
NBTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 43.9 million | 102.4 million |
2023-03-31 | 65.1 million | 94.6 million |
2022-12-31 | 64.1 million | 93.2 million |
2022-09-30 | 58.6 million | 85.1 million |
NBTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -9.6 million | 733407 |
2023-03-31 | -22.0 million | 988636 |
2022-12-31 | ? | ? |
2022-09-30 | -9.6 million | 889604 |
NBTX Net Income
No data available :(
NBTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 23.5 million | - | 5.7 million |
2023-03-31 | 45.1 million | - | - |
2022-12-31 | 44.4 million | - | 5.9 million |
2022-09-30 | 40.6 million | - | - |
NBTX Shares Outstanding
NBTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 175604 | 9.7 million | - | - |
2023-03-31 | 15260 | 16.9 million | - | - |
2022-12-31 | 6975 | - | - | - |
2022-09-30 | 6375 | 7.9 million | - | - |
NBTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 1.8 million | - |
2023-03-31 | 1.9 million | 821865 |
2022-12-31 | - | - |
2022-09-30 | 1.7 million | - |
NBTX
Price: $6.60
52 week price:
Earnings Per Share: -1.82 USD
P/E Ratio: -3.96
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 700
Market Capitalization: 310.5 million